Hyaluronan thiomer gel/matrix mediated healing of articular cartilage defects in New Zealand White rabbits—a pilot study
© The Author(s). 2017
Received: 31 January 2017
Accepted: 27 April 2017
Published: 3 May 2017
Articular cartilage defects are limited to their regenerative potential in human adults. Our current study evaluates tissue regeneration in a surgically induced empty defect site with hyaluronan thiomer as a provisional scaffold in a gel/matrix combination without cells on rabbit models to restore tissue formation.
An osteochondral defect of 4 mm in diameter and 5 mm in depth was induced by mechanical drilling in the femoral center of the trochlea in 18 New Zealand White rabbits. Previously evaluated from an in vitro study hyaluronan thiomer matrix, and a hyaluronan thiomer gel was used to treat the defect. As a control, the defect was left untreated. During the whole study, rabbits were clinically examined and after 4 (n = 3) or 12 (n = 3) weeks, the rabbits were sacrificed. Joints were evaluated macroscopically (Brittberg score) and by histology (O’Driscoll score). Synovial cells from the synovial fluid smear were histopathologically evaluated.
The healing of the defects varied intra-group wise at the first observation period. After 12 weeks the results concerning the cartilage repair score were inhomogeneous within each group, while the macroscopic analysis was more homogenous. In the synovial fluid smear, the mean score of infiltrated synovial and non-synovial cells was slightly increased after 4 weeks and slightly decreased after 12 weeks in both the treatment groups in comparison to the untreated control.
Taken together with results from the in vivo study indicated that implantation of hyaluronan thiomer as a combination of gel and matrix might enhance articular cartilage regeneration in an empty defect. Despite their benefits, the intrinsic healing capacity of New Zealand rabbits is a limitation for comparative test subject in pre-clinical models of cartilage defects.
The regeneration of articular cartilage has a limited potential as it is an avascular tissue and lacks access to progenitor cells (Solchaga et al. 2005; Aulin et al. 2013). Currently, many different biomaterials are under experimental investigation or are already used in clinical applications (Cook et al. 2016). These biomaterials are composed of natural polymers like collagen (Gille et al. 2010; Pascarella et al. 2010), agarose (Wang et al. 2011), hyaluronan (Solchaga et al. 2000; Kang et al. 2009), synthetic polymers (e.g. polylactic acid, polyglycolic acid) or a combination of both as composites. Hyaluronan (HA), a ubiquitous macromolecular polysaccharide of repeating units of N-acetyl-D-glucosamine and D-glucuronic acid is of great interest, as it is biocompatible, non-immunogenic and biodegradable (Necas et al. 2008). Currently, a diverse variety of HA-based biomaterials are available, but only a few are approved for clinical use (Albrecht et al. 2011). Non-crosslinked HA biomaterials degrade faster than crosslinked HA biomaterials under physiological conditions due to their high affinity to water and degradation by the enzyme hyaluronidase. HA biomaterials can be produced by chemical modification such as esterification of the carboxyl or hydroxyl groups by benzyl alcohol (HYAFFTM) (Benedetti et al. 1993). Auto cross-linking (non-covalent reactions), self-aggregation over hydrophobic interactions (Collins and Birkinshaw 2013; Dunkin and Lattermann 2013). Cross-Linking reactions can also be attained by carbodiimides, sulfides, aldehydes under acid, neutral or alkaline conditions or by the addition of synthetic linkers (Schanté et al. 2011). Alternatively, thiolated HA hydrogels offer better manipulation for mechanical properties and fabrication to defined shapes by either crosslinking with a thiol-reactive crosslinker or by oxidative disulfide formation (Wirostko et al. 2014). HA-based biomaterials are advantageous with biological properties that can bind to chondrocytes (Bauer et al. 2015) or mesenchymal stem cells (MSC’s) through the CD44 cell surface receptor (Jakobsen et al. 2010) and direct chondrogenic marker genes responsible for extracellular matrix production. HA scaffold investigated for one-stage cartilage repair combined with autologous bone marrow concentrates had superior clinical outcomes independent of the patient’s age or defect size post follow-up at 5 years (Gobbi and Whyte 2016).
Commonly used screening techniques for biomaterial based cartilage regeneration in pre-clinical small animal studies include by inducing a defect into the medial femoral condyle or the trochlear groove. Rabbits represent a species, which is very suitable to test new advanced biomaterials or new therapies as they can be handled easily, are relatively inexpensive and offer a good joint size for surgical procedures (Chu et al. 2010; Aulin et al. 2013). Larger animals, like e.g. sheep or goats, are relatively more expensive and reasonably considered to be used in later preclinical studies (Hurtig et al. 2011). The aim of the current pilot study is to examine the healing capacity of acellular cross-linked hyaluronan thiomer gel alone or gel + matrix scaffolds in surgically-induced chondral defects on femorotibial joints of New Zealand White rabbits.
The New Zealand White (NZW) rabbit is a suitable species for tolerability tests conventional to regulatory authorities and is entreated following the guideline ISO 10993–6. The study was conducted by the requirements of the Council Directive 86/609/EEC and subsequent amendments on the approximation of laws, regulations and administrative provisions regarding the protection of animals used for experimental and other scientific purposes or procedures. As no gender-specific differences are expected, only female animals were used in this study (Arzi et al. 2012). Eighteen NZW rabbits (8 months-old females, weight-range 4.3–5.5 kg) were purchased from S & K LAP Kft (Kartal, Hungary) in a good conventional health status. Before study initiation, the animals were accustomed to laboratory conditions for 2 weeks. A veterinarian on arrival examined the health status of the animals used in this study and before beginning the study. On the day of animal delivery, animals were allocated to the test groups and were marked individually by ear tags done by the supplier. Additionally, a waterproof ink was used to mark animals with their internal number on the inside of the ear. Room temperature was adjusted to 20 ± 3 °C, and the relative humidity was set at 30–70%. Artificial light was scheduled to give a cycle of 12 h light and 12 h dark (LD 12:12) with the light on at 6:30 a.m. Each rabbit was housed in a cage of stainless steel with the bottom grid. The animals were fed with a pellet diet and had access to tap water continuously.
Preparation of the test items
Scaffolds made of cross-linked HA were produced and provided by Croma Pharma GmbH (Leobendorf, Austria). HA was derivatized with a linker containing a thiol group. Thiol-modified HA was dissolved in deionized water at a concentration of 1.5% (w/v) and the pH adjusted to 7.1–7.3 using NaOH. The solution was poured into 12-well plates (0.9–2 g per well for different hydrogel heights) and kept at room temperature for 5 h. Under these conditions, thiol groups slowly form disulfide bridges. The resulting cross-linked hydrogel was lyophilized to obtain HA matrix using the following parameters: The plates were frozen overnight in an −80 °C freezer, followed by the primary drying step for 24 h. The temperature of product footprint was −10–−15 °C, while the condenser temperature was −50–−55 °C. The vacuum applied was 0.05–0.1 mbar. The secondary drying step was for 2 h using the same parameters. The resulting HA matrix was punched to obtain sizes suitable for in vivo experiments.
The 3.5% hyaluronan thiomer gel (HA gel) produced and provided by Croma Pharma GmbH (Leobendorf, Austria) in 80 mM phosphate buffer was diluted prior the surgical procedure with a buffer containing 0.06% H2O2 and 120 mM phosphate buffer. A ratio of 1:1 resulting in a final concentration of 1.75% HA gel, 0.03% H2O2, and 100 mM phosphate buffer.
Experimental design and surgical procedure
Experimental design—allocation of animals to treatment groups
Treatment group name
Injection volume gel [μl]
1.75% hyaluronan thiomer gel
Gel + matrix
1.75% hyaluronan thiomer gel + lyophilized 1.5% hyaluronan thiomer matrix
As a prophylaxis, all animals received a subcutaneous injection of an antibiotic (8.0 mg Cefovecin/kg b.w., Convenia®) approximately 2 h before surgery. Preoperatively, the rabbits were anesthetized with the combination of Medetomidine (0.3 mg/kg b.w., Cepetor®) and Ketamin (20.0 mg/kg b.w., Ketavet®) both administered intramuscularly. Analgesia was achieved with Carprofen (5.0 mg/kg b.w., Rimadyl®) given subcutaneously on the day of surgery and 6 days post-surgically. The animals received additional doses of Carprofen during the observation period when exhibited signs of pain.
The knee region was shaved and aseptically cleaned with an appropriate disinfection agent. The rabbits were covered with a sterile foil to keep them warm during surgery. Arthrotomy of the femorotibial joint was performed under aseptic conditions by an incision of the skin over the ligamentum patellae and an incision of the knee capsule. After dislocating the patella laterally, a chondral defect using a cordless screwdriver was drilled in the center of the trochlea. The defect was 4 mm in diameter, maximum 5 mm in depth and about 5 mm in the distance to the proximal trochlear ridge. Immediately after drilling the defect was rinsed with isotonic saline (0.9%). Then the HA gel was pipetted into the defect and let to polymerize for 3 min. For the animals of group 3 the lyophilized 1.5% hyaluronan thiomer matrix was placed into the chondral defect before it was filled up with HA gel. The defect of the untreated rabbits was rinsed before the knee capsule, and the skin region was sutured. The same closing procedure was performed in the treated rabbits. Aluminum Spray was used for wound closure. 30 min after surgery pain relief was reached by administrating Atipamezole (1.0 mg/kg b.w., i.m., Revertor®) to the animals.
Postoperatively observations were performed on day 1 of the study and monitored until the end of the observation period. Additionally, a cage side examination was performed daily on all animals. Particular attention was given to the surgery site and if the animal gained weight on the operated leg. At the end of both observation periods (4 and 12 weeks), the animals were sacrificed by an intravenous overdose of pentobarbiturate (150 mg/kg b.w.).
A macroscopic examination of the implantation site was performed by observing the appearance of the tissue in situ and by photographic documentation. Any abnormalities were recorded with details of the location, color, shape and size. Two smears from the synovial fluid were prepared, stained using hematoxylin and eosin (H & E) and May-Grünwald-Giemsa and evaluated following the suggestions from the ISO guideline 10993–6, Annex E, Table E.1. From each implanted knee, the implantation site (femur cartilage at knee joint) was collected for H & E and Safranin-O staining. A histopathological evaluation of the administration site was performed using O’Driscoll scoring.
For the O’Driscoll score, range from 0 to 24 is used, with 24 as the best scoring indicator. It uses different characteristics to build the score including cellular morphology, Safranin-O staining of the matrix, surface regularity and structural integrity. Also the thickness of the cartilage in the healing zone, bonding to the adjacent cartilage, hypocellularity within the tissue, chondrocyte clustering and freedom from degenerative changes in adjacent cartilage are considered (Rutgers et al. 2010).
The Brittberg score is a macroscopic scoring system which evaluates the quality of defect repair tissue and the integration with the surrounding cartilage, as well as the macroscopic appearance. Each section can score 0–4 points, and so the overall score ranges from 0 to 12 points, with 12 points indicating the best result (Grade I, normal repair). Grade II (nearly normal) ranges from 8 to 11 points, Grade III (abnormal) from 4 to 7 points and Grade IV (severely abnormal) from 1 to 3 points (Brittberg 2000).
For the histopathological evaluation of the synovia smear, synovial cells and non-synovial cells (polymorphonuclear cells, lymphocytes, plasma cells, macrophages and giant cells) were included in the scoring system. Different gradings were divided into 5 groups with 0 as no cells, 1 as rare cells (1–5 cells in the evaluated segment), 2 as 5–10 cells, 3 as strong infiltrations and 4 as packed.
A statistical analysis of data was performed for each group separately. Data values are reported as the mean ± standard deviation. Statistical analysis was performed using nonparametric Mann–Whitney U test with a confidence level of 95% or more.
Between the animal delivery and the surgery, the animals displayed a stagnating or positive body weight gain except for one rabbit, with a decrease in body weight as a result of reduced food consumption. In both treatment groups, single animals demonstrated a relieving posture of the right hind leg or an edema or hematoma formation, which was not observed in untreated animals. In 4 (out of 6) animals treated with 1.75% hyaluronan thiomer gel (HA gel), an increased incidence of swelling was noted at the surgery site only at some time points and in some animals with an increased body temperature (39.5 °C) and reduced food consumption. In comparison, the 1.75% hyaluronan thiomer gel and 1.5% hyaluronan thiomer matrix group (HA gel + matrix) exhibited a swelling at the surgery site in the first 3 weeks with reduced food consumption and discolored urine in 2 (out of 6) animals. A treatment-related influence could not be ruled out, but also the half of the untreated animals showed reddening or swelling of the skin in the surgery area. Nevertheless, all implantation sites and all animals were carried forward without any findings at the end of the second observation period.
Macroscopic findings (Brittberg score)
No treatment-related findings were noted at the implantation site of any animals at either time point (Fig. 2a–c). At the end of the first observation period (4 weeks), a single nodule of soft consistency in subcutis near the implantation site was noted in 2 (out of 3) untreated animals. Also in 1 (out of 3) animals treated with HA gel and 2 (out of 3) animals treated with the HA gel + matrix. These findings could be the outcome from surgical injury and not influenced by the treatment method. At the end of the second observation period (12 weeks), the only macroscopic finding noted in one animal treated with HA gel was a red fluid in the uterus. The reason for this could not be clarified but was assumed to be unrelated to the test item.
The results of the 12 week observation period were more homogenous, and a nearly normal regeneration was visible in all animals except one in the HA gel group.
Histopathological findings (O’Driscoll score)
The main findings of this study in a surgically induced chondral defect of NZW rabbits were: 1) macroscopic observations revealed no differences regarding inflammatory response when the defect was filled with either a hyaluronan thiomer gel (HA gel) or hyaluronan thiomer gel + hyaluronan thiomer matrix (HA gel + matrix) at the transplantation site. 2) Histopathological results denoted that the HA gel + matrix group enhanced comparable cartilage tissue repair at the defect with an increase in cell growth around the tissue after 4 weeks compared to HA gel alone and the empty defect control. The tissue repair process was delayed in the first week’s post implantation of HA gel alone group into the defect; however, the tissue repair process was similar to HA gel + matrix group as well as the empty defect control at the end point of evaluation. Together we observed that the tissue repair process is inconsequential to either of these treatment groups post 12 weeks.
The results are in accordance with reported studies that have explicated that an injectable gel or matrices of hyaluronan may have a healing potential in articular cartilage defects (Cecilia et al. 2010; Leela et al. 2008). Cross-linked hyaluronan gels or matrices by chemical modification not only provide mechanical stability but also retain the biocompatibility and a slower retention of degradation (Collins and Birkinshaw 2008). Although the surgical defect in all groups was induced in the trochlear groove which is primarily secluded from the synovium and provided with a prominent blood supply, no immune response was witnessed upon implantation.
It has been demonstrated in a rabbit model, that an adaptive immune response in defects from the patellar and trochlear groove upon implantation of an allogenic matrix is primarily intermediated by the vicinity of the synovium and not in contact with the blood supply (Arzi et al. 2015). The clinical evaluation revealed that an edema or a relieving posture of the hind leg at the defect site in the HA gel or HA gel + matrix groups, followed by an increase in the incidence of swelling, increased body temperature, reduced food consumption and discolored urine or feces in the test subjects. Nevertheless, the body weight gain was not influenced post implantation.
Limitations to our current study include the 4 mm2 lesion size criteria induced in the chondral defect. A larger defect could have prevented the endogenous healing in the empty defect control group. Another limitation of our study is the endogenous healing capacity in rabbit knees which is a well-known occurring phenomenon (Nishizawa et al. 2010; Terajima et al. 2012; Kawamura et al. 1998). Wei et al. earlier reported when untreated full-thickness cartilage defects were studied in young, adolescence and adult rabbits; spontaneous tissue repair occurred with a faster healing in young animals than adults despite the compromise of mechanical stiffness than that in the native tissue (Wei and Messner 1999). This study emphasized the potential of self-healing in rabbits decrease over age and maturation of the tissue. In our present study, the rabbits investigated were 8-month-old young animals reporting the same mechanism of self-healing in the untreated defect control groups. This marks the evaluation among other treatment groups for a less comparative analysis to the untreated defect denoting the rabbit model relatively less reliable to our study design.
Our study implies cartilaginous tissue formation in vivo by using a cross-linked hyaluronan as a provisional scaffold. However, the rabbit animal model in the current study resulted in a spontaneous tissue repair in the untreated control group. It is of importance to consider a relevant in vivo model to develop further proof of concepts from an in vitro study to a preclinical model. In summary, we have tested a cytocompatible space filing HA gel and gel + matrix that fills in space around defects to cartilage in situ. The HA gel alone or gel + matrix combination is a significant carrier for an arthroscopically matrix-assisted cartilage repair technique for cell or cell-free regenerative therapies. The in situ defect filling carrier referred in here can support in vitro and in vivo matrix formation, ensuring its stability in articular cartilage defects in vivo for up to 12 weeks.
The authors would like to acknowledge the Austrian Research Promotion Agency (FFG, grant 820129) and Croma Pharma GmbH Austria for supporting this study. We thank Aurigon Life Science GmbH for performing the animal experiments.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
SN and CB acquired funding for this research. CB, ENM and DK contributed to the conception and design of the study and acquired data. CB, ENM, VJ and SN contributed to the analysis and interpretation of these data. CB, VJ and SN drafted the manuscript. All authors reviewed, revised and provided final approval of this manuscript before submission.
The authors declare that they have no competing interests.
Consent for publication
Ethical approval for this study was obtained from the Regional Ethical Committee (GS4-EK-4/064-2009).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Albrecht C, Tichy B, Nürnberger S et al (2011) Gene expression and cell differentiation in matrix-associated chondrocyte transplantation grafts: a comparative study. Osteoarthr Cartil 19:1219–1227. doi:10.1016/j.joca.2011.07.004 View ArticlePubMedGoogle Scholar
- Arzi B, Wisner ER, Huey DJ et al (2012) RESEARCH NOTE A proposed model of naturally occurring osteoarthritis in the domestic rabbitGoogle Scholar
- Arzi B, Duraine GD, Lee CA et al (2015) Cartilage immunoprivilege depends on donor source and lesion location. Acta Biomater 23:72–81. doi:10.1016/j.actbio.2015.05.025 View ArticlePubMedPubMed CentralGoogle Scholar
- Aulin C, Jensen-Waern M, Ekman S et al (2013) Cartilage repair of experimentally 11 induced osteochondral defects in New Zealand White rabbits. Lab Anim 47:58–65. doi:10.1177/0023677212473716 View ArticlePubMedGoogle Scholar
- Bauer C, Berger M, Baumgartner RR et al (2015) A novel cross-linked hyaluronic acid porous scaffold for cartilage repair: an in vitro study with osteoarthritic chondrocytes. Cartilage. doi: 10.1177/1947603515611949
- Benedetti L, Cortivo R, Berti T et al (1993) Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials 14:1154–1160View ArticlePubMedGoogle Scholar
- Brittberg M (2000) Evaluation of cartilage injuries and cartilage repair. Osteologie 9:17–25Google Scholar
- Cecilia A, Kristoffer B, Marianne J-W, Patricia Hedenqvist J, Hilborn O, Thomas E (2010) In situ cross-linkable hyaluronan hydrogel enhances chondrogenesis. J Tissue Eng Regen Med 4:524–531. doi:10.1002/term View ArticleGoogle Scholar
- Chu CR, Szczodry M, Bruno S (2010) Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev 16:105–15. doi:10.1089/ten.TEB.2009.0452 View ArticlePubMedPubMed CentralGoogle Scholar
- Collins MN, Birkinshaw C (2008) Physical properties of crosslinked hyaluronic acid hydrogels. J Mater Sci Mater Med 19:3335–3343. doi:10.1007/s10856-008-3476-4 View ArticlePubMedGoogle Scholar
- Collins MN, Birkinshaw C (2013) Hyaluronic acid based scaffolds for tissue engineering - a review. Carbohydr Polym 92:1262–1279. doi:10.1016/j.carbpol.2012.10.028 View ArticlePubMedGoogle Scholar
- Cook JL, Stannard JP, Stoker AM et al (2016) Importance of donor chondrocyte viability for osteochondral allografts. Am J Sports Med 44:1260–8. doi:10.1177/0363546516629434 View ArticlePubMedGoogle Scholar
- Dunkin BS, Lattermann C (2013) New and emerging techniques in cartilage repair: MACI. Oper Tech Sports Med 21:100–107. doi:10.1053/j.otsm.2013.03.003 View ArticlePubMedPubMed CentralGoogle Scholar
- Gille J, Schuseil E, Wimmer J et al (2010) Mid-term results of autologous matrix-induced chondrogenesis for treatment of focal cartilage defects in the knee. Knee Surg Sports Traumatol Arthrosc 18:1456–1464. doi:10.1007/s00167-010-1042-3 View ArticlePubMedGoogle Scholar
- Gobbi A, Whyte GP (2016) One-stage cartilage repair using a hyaluronic acid–based scaffold with activated bone marrow–derived mesenchymal stem cells compared with microfracture. Am J Sports Med 44:2846–2854. doi:10.1177/0363546516656179 View ArticlePubMedGoogle Scholar
- Hurtig MB, Buschmann MD, Fortier LA et al (2011) Preclinical studies for cartilage repair: recommendations from the international cartilage repair society. Cartilage 2:137–152. doi:10.1177/1947603511401905 View ArticlePubMedPubMed CentralGoogle Scholar
- Jakobsen RB, Shahdadfar A, Reinholt FP, Brinchmann JE (2010) Chondrogenesis in a hyaluronic acid scaffold: comparison between chondrocytes and MSC from bone marrow and adipose tissue. Knee Surg Sports Traumatol Arthrosc 18:1407–1416. doi:10.1007/s00167-009-1017-4 View ArticlePubMedGoogle Scholar
- Kang JY, Chung CW, Sung JH et al (2009) Novel porous matrix of hyaluronic acid for the three-dimensional culture of chondrocytes. Int J Pharm 369:114–120. doi:10.1016/j.ijpharm.2008.11.008 View ArticlePubMedGoogle Scholar
- Kawamura S, Wakitani S, Kimura T et al (1998) Articular cartilage repair. Rabbit experiments with a collagen gel-biomatrix and chondrocytes cultured in it. Acta Orthop Scand 69:56–62. doi:10.3109/17453679809002358 View ArticlePubMedGoogle Scholar
- Leela SKÆ, Bada P, Lee ÆCKÆJ et al (2008) Articular cartilage regeneration with microfracture and hyaluronic acid. Biotechnol Lett 30:435–9. doi:10.1007/s10529-007-9576-2 View ArticleGoogle Scholar
- Necas J, Bartosikova L, Brauner P, Kolar J (2008) Hyaluronic acid (hyaluronan): a review. Vet Med (Praha) 53:397–411Google Scholar
- Nishizawa K, Imai S, Mimura T et al (2010) In-advance trans-medullary stimulation of bone marrow enhances spontaneous repair of full-thickness articular cartilage defects in rabbits. Cell Tissue Res 341:371–379. doi:10.1007/s00441-010-1020-6 View ArticlePubMedGoogle Scholar
- Pascarella A, Ciatti R, Pascarella F et al (2010) Treatment of articular cartilage lesions of the knee joint using a modified AMIC technique. Knee Surg Sports Traumatol Arthrosc 18:509–513. doi:10.1007/s00167-009-1007-6 View ArticlePubMedGoogle Scholar
- Rutgers M, van Pelt MJP, Dhert WJA et al (2010) Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage. Osteoarthr Cartil 18:12–23View ArticlePubMedGoogle Scholar
- Schanté CE, Zuber G, Herlin C, Vandamme TF (2011) Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr Polym 85:469–489. doi:10.1016/j.carbpol.2011.03.019 View ArticleGoogle Scholar
- Solchaga LA, Yoo JU, Lundberg M et al (2000) Hyaluronan-based polymers in the treatment of osteochondral defects. J Orthop Res 18:773–780. doi:10.1002/jor.1100180515 View ArticlePubMedGoogle Scholar
- Solchaga LA, Temenoff JS, Gao J et al (2005) Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthr Cartil 13:297–309. doi:10.1016/j.joca.2004.12.016 View ArticlePubMedGoogle Scholar
- Terajima M, Damle S, Penmatsa M et al (2012) Temporal changes in collagen cross-links in spontaneous articular cartilage repair. Cartilage 3:278–287. doi:10.1177/1947603512437736 View ArticlePubMed CentralGoogle Scholar
- Wang CC, Yang KC, Lin KH et al (2011) A highly organized three-dimensional alginate scaffold for cartilage tissue engineering prepared by microfluidic technology. Biomaterials 32:7118–7126. doi:10.1016/j.biomaterials.2011.06.018 View ArticlePubMedGoogle Scholar
- Wei X, Messner K (1999) Maturation-dependent durability of spontaneous cartilage repair in rabbit knee joint. J Biomed Mater Res 46:539–548View ArticlePubMedGoogle Scholar
- Wirostko B, Mann BK, Williams DL, Prestwich GD (2014) Ophthalmic uses of a thiol-modified hyaluronan-based hydrogel. Adv Wound Care 3:708–716. doi:10.1089/wound.2014.0572 View ArticleGoogle Scholar